Acelyrin, Inc. (SLRN) Misses Q3 EPS by 39c
Tweet
Share
E-mail
Get Alerts SLRN Hot Sheet
Join SI Premium – FREE
Acelyrin, Inc. (NASDAQ: SLRN) reported Q3 EPS of ($0.87), $0.39 worse than the analyst estimate of ($0.48).
For earnings history and earnings-related data on Acelyrin, Inc. (SLRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- KeyBanc Upgrades Nucor (NUE) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
